カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界のジカウイルス治療薬市場予測2023-2029：アセトアミノフェン、その他のNSAIDs

【英語タイトル】Zika Virus Therapeutic Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8762）・商品コード：MMG23LY8762
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：61
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のジカウイルス治療薬市場規模と予測を収録しています。・世界のジカウイルス治療薬市場：売上、2018年-2023年、2024年-2029年
・世界のジカウイルス治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のジカウイルス治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アセトアミノフェン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ジカウイルス治療薬のグローバル主要企業は、Johnson and Johnson、 Aurobindo Pharma、 Granules India、 Perrigo、 Sun Pharmaceutical、 Bharat Biotech、 Emergent BioSolutions、 Takeda Pharmaceutical、 GeoVax Labs、 IMV、 Inovio Pharmaceuticals、 Moderna、 Merck、 Valnevaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ジカウイルス治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のジカウイルス治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のジカウイルス治療薬市場：タイプ別市場シェア、2022年
・アセトアミノフェン、その他のNSAIDs

世界のジカウイルス治療薬市場：用途別、2018年-2023年、2024年-2029年
世界のジカウイルス治療薬市場：用途別市場シェア、2022年
・機関薬局、小売薬局、その他

世界のジカウイルス治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のジカウイルス治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるジカウイルス治療薬のグローバル売上、2018年-2023年
・主要企業におけるジカウイルス治療薬のグローバル売上シェア、2022年
・主要企業におけるジカウイルス治療薬のグローバル販売量、2018年-2023年
・主要企業におけるジカウイルス治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Johnson and Johnson、 Aurobindo Pharma、 Granules India、 Perrigo、 Sun Pharmaceutical、 Bharat Biotech、 Emergent BioSolutions、 Takeda Pharmaceutical、 GeoVax Labs、 IMV、 Inovio Pharmaceuticals、 Moderna、 Merck、 Valneva

*************************************************************

・調査・分析レポートの概要
ジカウイルス治療薬市場の定義
市場セグメント
世界のジカウイルス治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のジカウイルス治療薬市場規模
世界のジカウイルス治療薬市場規模：2022年 VS 2029年
世界のジカウイルス治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのジカウイルス治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のジカウイルス治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：アセトアミノフェン、その他のNSAIDs
ジカウイルス治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：機関薬局、小売薬局、その他
ジカウイルス治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別ジカウイルス治療薬市場規模 2022年と2029年
地域別ジカウイルス治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Johnson and Johnson、 Aurobindo Pharma、 Granules India、 Perrigo、 Sun Pharmaceutical、 Bharat Biotech、 Emergent BioSolutions、 Takeda Pharmaceutical、 GeoVax Labs、 IMV、 Inovio Pharmaceuticals、 Moderna、 Merck、 Valneva
...

Zika virus infection is triggered by an Aedes mosquito-borne virus that bites during the day. In general, the symptoms include fever, rash, conjunctivitis, muscle and joint pain, malaise, or headache.
This report aims to provide a comprehensive presentation of the global market for Zika Virus Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zika Virus Therapeutic. This report contains market size and forecasts of Zika Virus Therapeutic in global, including the following market information:
Global Zika Virus Therapeutic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Zika Virus Therapeutic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Acetaminophen Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Zika Virus Therapeutic include Johnson and Johnson, Aurobindo Pharma, Granules India, Perrigo, Sun Pharmaceutical, Bharat Biotech, Emergent BioSolutions, Takeda Pharmaceutical and GeoVax Labs, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Zika Virus Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zika Virus Therapeutic Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Zika Virus Therapeutic Market Segment Percentages, by Type, 2022 (%)
Acetaminophen
Other NSAIDs
Global Zika Virus Therapeutic Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Zika Virus Therapeutic Market Segment Percentages, by Application, 2022 (%)
Institutional Pharmacies
Retail Pharmacies
Others
Global Zika Virus Therapeutic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Zika Virus Therapeutic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Zika Virus Therapeutic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Zika Virus Therapeutic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson and Johnson
Aurobindo Pharma
Granules India
Perrigo
Sun Pharmaceutical
Bharat Biotech
Emergent BioSolutions
Takeda Pharmaceutical
GeoVax Labs
IMV
Inovio Pharmaceuticals
Moderna
Merck
Valneva
Outline of Major Chapters:
Chapter 1: Introduces the definition of Zika Virus Therapeutic, market overview.
Chapter 2: Global Zika Virus Therapeutic market size in revenue.
Chapter 3: Detailed analysis of Zika Virus Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Zika Virus Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Zika Virus Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Zika Virus Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Zika Virus Therapeutic Overall Market Size
2.1 Global Zika Virus Therapeutic Market Size: 2022 VS 2029
2.2 Global Zika Virus Therapeutic Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Zika Virus Therapeutic Players in Global Market
3.2 Top Global Zika Virus Therapeutic Companies Ranked by Revenue
3.3 Global Zika Virus Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Zika Virus Therapeutic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Zika Virus Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Zika Virus Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Zika Virus Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Zika Virus Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Zika Virus Therapeutic Market Size Markets, 2022 & 2029
4.1.2 Acetaminophen
4.1.3 Other NSAIDs
4.2 By Type – Global Zika Virus Therapeutic Revenue & Forecasts
4.2.1 By Type – Global Zika Virus Therapeutic Revenue, 2018-2023
4.2.2 By Type – Global Zika Virus Therapeutic Revenue, 2024-2029
4.2.3 By Type – Global Zika Virus Therapeutic Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Zika Virus Therapeutic Market Size, 2022 & 2029
5.1.2 Institutional Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Others
5.2 By Application – Global Zika Virus Therapeutic Revenue & Forecasts
5.2.1 By Application – Global Zika Virus Therapeutic Revenue, 2018-2023
5.2.2 By Application – Global Zika Virus Therapeutic Revenue, 2024-2029
5.2.3 By Application – Global Zika Virus Therapeutic Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Zika Virus Therapeutic Market Size, 2022 & 2029
6.2 By Region – Global Zika Virus Therapeutic Revenue & Forecasts
6.2.1 By Region – Global Zika Virus Therapeutic Revenue, 2018-2023
6.2.2 By Region – Global Zika Virus Therapeutic Revenue, 2024-2029
6.2.3 By Region – Global Zika Virus Therapeutic Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Zika Virus Therapeutic Revenue, 2018-2029
6.3.2 US Zika Virus Therapeutic Market Size, 2018-2029
6.3.3 Canada Zika Virus Therapeutic Market Size, 2018-2029
6.3.4 Mexico Zika Virus Therapeutic Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Zika Virus Therapeutic Revenue, 2018-2029
6.4.2 Germany Zika Virus Therapeutic Market Size, 2018-2029
6.4.3 France Zika Virus Therapeutic Market Size, 2018-2029
6.4.4 U.K. Zika Virus Therapeutic Market Size, 2018-2029
6.4.5 Italy Zika Virus Therapeutic Market Size, 2018-2029
6.4.6 Russia Zika Virus Therapeutic Market Size, 2018-2029
6.4.7 Nordic Countries Zika Virus Therapeutic Market Size, 2018-2029
6.4.8 Benelux Zika Virus Therapeutic Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Zika Virus Therapeutic Revenue, 2018-2029
6.5.2 China Zika Virus Therapeutic Market Size, 2018-2029
6.5.3 Japan Zika Virus Therapeutic Market Size, 2018-2029
6.5.4 South Korea Zika Virus Therapeutic Market Size, 2018-2029
6.5.5 Southeast Asia Zika Virus Therapeutic Market Size, 2018-2029
6.5.6 India Zika Virus Therapeutic Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Zika Virus Therapeutic Revenue, 2018-2029
6.6.2 Brazil Zika Virus Therapeutic Market Size, 2018-2029
6.6.3 Argentina Zika Virus Therapeutic Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Zika Virus Therapeutic Revenue, 2018-2029
6.7.2 Turkey Zika Virus Therapeutic Market Size, 2018-2029
6.7.3 Israel Zika Virus Therapeutic Market Size, 2018-2029
6.7.4 Saudi Arabia Zika Virus Therapeutic Market Size, 2018-2029
6.7.5 UAE Zika Virus Therapeutic Market Size, 2018-2029
7 Zika Virus Therapeutic Companies Profiles
7.1 Johnson and Johnson
7.1.1 Johnson and Johnson Company Summary
7.1.2 Johnson and Johnson Business Overview
7.1.3 Johnson and Johnson Zika Virus Therapeutic Major Product Offerings
7.1.4 Johnson and Johnson Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.1.5 Johnson and Johnson Key News & Latest Developments
7.2 Aurobindo Pharma
7.2.1 Aurobindo Pharma Company Summary
7.2.2 Aurobindo Pharma Business Overview
7.2.3 Aurobindo Pharma Zika Virus Therapeutic Major Product Offerings
7.2.4 Aurobindo Pharma Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.2.5 Aurobindo Pharma Key News & Latest Developments
7.3 Granules India
7.3.1 Granules India Company Summary
7.3.2 Granules India Business Overview
7.3.3 Granules India Zika Virus Therapeutic Major Product Offerings
7.3.4 Granules India Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.3.5 Granules India Key News & Latest Developments
7.4 Perrigo
7.4.1 Perrigo Company Summary
7.4.2 Perrigo Business Overview
7.4.3 Perrigo Zika Virus Therapeutic Major Product Offerings
7.4.4 Perrigo Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.4.5 Perrigo Key News & Latest Developments
7.5 Sun Pharmaceutical
7.5.1 Sun Pharmaceutical Company Summary
7.5.2 Sun Pharmaceutical Business Overview
7.5.3 Sun Pharmaceutical Zika Virus Therapeutic Major Product Offerings
7.5.4 Sun Pharmaceutical Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.5.5 Sun Pharmaceutical Key News & Latest Developments
7.6 Bharat Biotech
7.6.1 Bharat Biotech Company Summary
7.6.2 Bharat Biotech Business Overview
7.6.3 Bharat Biotech Zika Virus Therapeutic Major Product Offerings
7.6.4 Bharat Biotech Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.6.5 Bharat Biotech Key News & Latest Developments
7.7 Emergent BioSolutions
7.7.1 Emergent BioSolutions Company Summary
7.7.2 Emergent BioSolutions Business Overview
7.7.3 Emergent BioSolutions Zika Virus Therapeutic Major Product Offerings
7.7.4 Emergent BioSolutions Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.7.5 Emergent BioSolutions Key News & Latest Developments
7.8 Takeda Pharmaceutical
7.8.1 Takeda Pharmaceutical Company Summary
7.8.2 Takeda Pharmaceutical Business Overview
7.8.3 Takeda Pharmaceutical Zika Virus Therapeutic Major Product Offerings
7.8.4 Takeda Pharmaceutical Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.8.5 Takeda Pharmaceutical Key News & Latest Developments
7.9 GeoVax Labs
7.9.1 GeoVax Labs Company Summary
7.9.2 GeoVax Labs Business Overview
7.9.3 GeoVax Labs Zika Virus Therapeutic Major Product Offerings
7.9.4 GeoVax Labs Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.9.5 GeoVax Labs Key News & Latest Developments
7.10 IMV
7.10.1 IMV Company Summary
7.10.2 IMV Business Overview
7.10.3 IMV Zika Virus Therapeutic Major Product Offerings
7.10.4 IMV Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.10.5 IMV Key News & Latest Developments
7.11 Inovio Pharmaceuticals
7.11.1 Inovio Pharmaceuticals Company Summary
7.11.2 Inovio Pharmaceuticals Business Overview
7.11.3 Inovio Pharmaceuticals Zika Virus Therapeutic Major Product Offerings
7.11.4 Inovio Pharmaceuticals Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.11.5 Inovio Pharmaceuticals Key News & Latest Developments
7.12 Moderna
7.12.1 Moderna Company Summary
7.12.2 Moderna Business Overview
7.12.3 Moderna Zika Virus Therapeutic Major Product Offerings
7.12.4 Moderna Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.12.5 Moderna Key News & Latest Developments
7.13 Merck
7.13.1 Merck Company Summary
7.13.2 Merck Business Overview
7.13.3 Merck Zika Virus Therapeutic Major Product Offerings
7.13.4 Merck Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.13.5 Merck Key News & Latest Developments
7.14 Valneva
7.14.1 Valneva Company Summary
7.14.2 Valneva Business Overview
7.14.3 Valneva Zika Virus Therapeutic Major Product Offerings
7.14.4 Valneva Zika Virus Therapeutic Revenue in Global Market (2018-2023)
7.14.5 Valneva Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Zika Virus Therapeutic Market Opportunities & Trends in Global Market
Table 2. Zika Virus Therapeutic Market Drivers in Global Market
Table 3. Zika Virus Therapeutic Market Restraints in Global Market
Table 4. Key Players of Zika Virus Therapeutic in Global Market
Table 5. Top Zika Virus Therapeutic Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Zika Virus Therapeutic Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Zika Virus Therapeutic Revenue Share by Companies, 2018-2023
Table 8. Global Companies Zika Virus Therapeutic Product Type
Table 9. List of Global Tier 1 Zika Virus Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Zika Virus Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Zika Virus Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Zika Virus Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Zika Virus Therapeutic Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Zika Virus Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Zika Virus Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Zika Virus Therapeutic Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Zika Virus Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Zika Virus Therapeutic Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Zika Virus Therapeutic Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Zika Virus Therapeutic Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Zika Virus Therapeutic Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Zika Virus Therapeutic Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Zika Virus Therapeutic Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Zika Virus Therapeutic Revenue, (US$, Mn), 2024-2029
Table 30. Johnson and Johnson Company Summary
Table 31. Johnson and Johnson Zika Virus Therapeutic Product Offerings
Table 32. Johnson and Johnson Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson and Johnson Key News & Latest Developments
Table 34. Aurobindo Pharma Company Summary
Table 35. Aurobindo Pharma Zika Virus Therapeutic Product Offerings
Table 36. Aurobindo Pharma Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 37. Aurobindo Pharma Key News & Latest Developments
Table 38. Granules India Company Summary
Table 39. Granules India Zika Virus Therapeutic Product Offerings
Table 40. Granules India Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 41. Granules India Key News & Latest Developments
Table 42. Perrigo Company Summary
Table 43. Perrigo Zika Virus Therapeutic Product Offerings
Table 44. Perrigo Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 45. Perrigo Key News & Latest Developments
Table 46. Sun Pharmaceutical Company Summary
Table 47. Sun Pharmaceutical Zika Virus Therapeutic Product Offerings
Table 48. Sun Pharmaceutical Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 49. Sun Pharmaceutical Key News & Latest Developments
Table 50. Bharat Biotech Company Summary
Table 51. Bharat Biotech Zika Virus Therapeutic Product Offerings
Table 52. Bharat Biotech Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 53. Bharat Biotech Key News & Latest Developments
Table 54. Emergent BioSolutions Company Summary
Table 55. Emergent BioSolutions Zika Virus Therapeutic Product Offerings
Table 56. Emergent BioSolutions Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 57. Emergent BioSolutions Key News & Latest Developments
Table 58. Takeda Pharmaceutical Company Summary
Table 59. Takeda Pharmaceutical Zika Virus Therapeutic Product Offerings
Table 60. Takeda Pharmaceutical Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 61. Takeda Pharmaceutical Key News & Latest Developments
Table 62. GeoVax Labs Company Summary
Table 63. GeoVax Labs Zika Virus Therapeutic Product Offerings
Table 64. GeoVax Labs Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 65. GeoVax Labs Key News & Latest Developments
Table 66. IMV Company Summary
Table 67. IMV Zika Virus Therapeutic Product Offerings
Table 68. IMV Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 69. IMV Key News & Latest Developments
Table 70. Inovio Pharmaceuticals Company Summary
Table 71. Inovio Pharmaceuticals Zika Virus Therapeutic Product Offerings
Table 72. Inovio Pharmaceuticals Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 73. Inovio Pharmaceuticals Key News & Latest Developments
Table 74. Moderna Company Summary
Table 75. Moderna Zika Virus Therapeutic Product Offerings
Table 76. Moderna Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 77. Moderna Key News & Latest Developments
Table 78. Merck Company Summary
Table 79. Merck Zika Virus Therapeutic Product Offerings
Table 80. Merck Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 81. Merck Key News & Latest Developments
Table 82. Valneva Company Summary
Table 83. Valneva Zika Virus Therapeutic Product Offerings
Table 84. Valneva Zika Virus Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 85. Valneva Key News & Latest Developments
List of Figures
Figure 1. Zika Virus Therapeutic Segment by Type in 2022
Figure 2. Zika Virus Therapeutic Segment by Application in 2022
Figure 3. Global Zika Virus Therapeutic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Zika Virus Therapeutic Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Zika Virus Therapeutic Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Zika Virus Therapeutic Revenue in 2022
Figure 8. By Type - Global Zika Virus Therapeutic Revenue Market Share, 2018-2029
Figure 9. By Application - Global Zika Virus Therapeutic Revenue Market Share, 2018-2029
Figure 10. By Type - Global Zika Virus Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Zika Virus Therapeutic Revenue Market Share, 2018-2029
Figure 12. By Application - Global Zika Virus Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Zika Virus Therapeutic Revenue Market Share, 2018-2029
Figure 14. By Region - Global Zika Virus Therapeutic Revenue Market Share, 2018-2029
Figure 15. By Country - North America Zika Virus Therapeutic Revenue Market Share, 2018-2029
Figure 16. US Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Zika Virus Therapeutic Revenue Market Share, 2018-2029
Figure 20. Germany Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 21. France Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Zika Virus Therapeutic Revenue Market Share, 2018-2029
Figure 28. China Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 32. India Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Zika Virus Therapeutic Revenue Market Share, 2018-2029
Figure 34. Brazil Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Zika Virus Therapeutic Revenue Market Share, 2018-2029
Figure 37. Turkey Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Zika Virus Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 41. Johnson and Johnson Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Aurobindo Pharma Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Granules India Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Perrigo Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sun Pharmaceutical Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bharat Biotech Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Emergent BioSolutions Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Takeda Pharmaceutical Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GeoVax Labs Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. IMV Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Inovio Pharmaceuticals Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Moderna Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Merck Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Valneva Zika Virus Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界のジカウイルス治療薬市場予測2023-2029：アセトアミノフェン、その他のNSAIDs] (コード：MMG23LY8762)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のジカウイルス治療薬市場予測2023-2029：アセトアミノフェン、その他のNSAIDs]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のウイルス様粒子市場予測2023-2029：アデノ随伴ウイルス、HIV、B型肝炎ウイルス、C型肝炎ウイルス、その他
  • 世界の水痘ウイルス生ワクチン市場予測2023-2029：子供、大人
  • 世界の原発性免疫不全治療薬市場予測2023-2029：免疫グロブリン補充療法、幹細胞/骨髄移植、抗生物質療法、遺伝子療法、その他
  • 世界のウイルス濾過膜市場予測2023-2029：限外濾過膜、ナノ濾過
  • 世界の治療用呼吸器装置市場予測2023-2029：持続気道陽圧装置、バイレベル気道陽圧装置

    • ◆H&Iグローバルリサーチのお客様（例）◆